Sir,
In systemic lupus erythematosus (SLE), lupus flares can be difficult to distinguish from infections because of similar clinical presentations.
We report the case of a 23-year-old woman diagnosed with SLE six years ago who presented with fever and severe arthralgias of two days' duration. At initial diagnosis, she presented with fatigue, arthritis, malar rash and typical immunological markers (increased ANA, dsDNA, low complement factors). She had been in remission with 5 mg/day of prednisone, 150 mg/day of azathioprine and 400 mg/day of hydroxychloroquine. On admission, she did not report vomiting, diarrhoea, cough or dysuria. On clinical examination, she had a malar rash, fever, tachycardia and arthritis of the hands and feet.
Blood tests revealed anaemia (haemoglobin 9.6 g/dL, N: 11.5-15.0 g/dL), mild leukopenia (3980/mL, N: 4000-11000/mL) with lymphopenia of 4%, lactate dehydrogenase 496 U/L (N: <247 U/L), CRP 278 mg/L (N: <5.0 mg/L) and procalcitonin 32.4 mg/L (N: <0.2 mg/L). Immunological studies indicated high disease activity, with elevated anti-dsDNA antibodies (326 lU/mL, N: <15 IU/mL) and reduced levels of C3 and C4 complement factors (0.74 and 0.06 g/L, respectively, N: 0.82-1.93 g/L, 0.15-0.57 g/L). ANA (1:3200), anti-SSA (>240 U/ mL, N: <7 U/mL) and anti-histone (>200 U/ml, N: <15 U/mL) antibodies were also increased.
A lupus flare was suspected and oral prednisone treatment of 2 mg/kg/day was initiated. Because of strikingly elevated CRP and procalcitonin levels, empirical antibiotic therapy (piperacillin/tazobactam) was started one day after admission, but terminated three days later because no infectious agent could be identified (blood, urine and stool Figure 1 The patient's disease course demonstrating increased procalcitonin levels and temperature, which rapidly subsided upon intensified prednisone treatment. cultures returned negative) and a thorough search for sites of infection with abdominal ultrasound, chest radiography, echocardiography and 18 Ffluorodeoxyglucose positron emission tomography/computed tomography scan (PET/CT) did not show any pathological results.
After reduction of prednisone to 1 mg/kg/day, symptoms recurred with fever of up to 39.2 C and severe arthritis requiring a dose increase to 2 mg/kg/day. Symptoms and blood tests gradually improved and she returned to her usual treatment regimen (Figure 1) .
This case illustrates that in SLE patients presenting with clinical findings compatible with infection/ lupus flare and elevated procalcitonin levels, a comprehensive diagnostic work-up is mandatory. 1 PET/CT has been reported as a useful tool to help with this distinction. 2 Recently, the literature on procalcitonin measurement in rheumatic conditions (including SLE) has been reviewed, concluding that most should be procalcitonin-negative in the absence of infection (ANCA-associated vasculitis and adult-onset Still's disease being exceptions). 3 The literature on the usefulness of procalcitonin is heterogeneous, some authors report no correlation of procalcitonin levels and SLE activity, proposing its usefulness for differentiation between flare and infection, 4,5 while others found the contrary. 6 Normally, high procalcitonin levels should suggest a severe bacterial (or fungal) infection; however, we believe that this was not the case in our patient given the negative work-up and prompt response to intensified prednisone treatment. Thus, elevations of procalcitonin might rarely be present in a lupus flare without infection acknowledging the fact that the literature on this topic is controversial.
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